BAJAJ BROKING

Notification close image
No new Notification messages
card image
Amanta Healthcare Ltd IPO
Apply for the Amanta Healthcare Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

544445

APL

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

Asston Pharmaceuticals Ltd Share Price Update

As of the latest trading session, Asston Pharmaceuticals Ltd share price is currently at ₹ 102.1, which is up by ₹ 4.26 from its previous closing. Today, the stock has fluctuated between ₹ 96.00 and ₹ 102.90. Over the past year, Asston Pharmaceuticals Ltd has achieved a return of 0.00 %. In the last month alone, the return has been -12.87 %. Read More...

Investment Returns

Over 1 Month -12.87% Over 3 Months -21.69% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Asston Pharmaceuticals Ltd fundamentals


  • Market cap (Cr)

  • P/E Ratio (TTM)

  • Beta

  • Book Value / share

  • Return on equity

    %

  • EPS (TTM)

  • Dividend yield

    %

  • Net profit/quarter (Cr)

info icon alternate text
  • Market cap (Cr)

    86.90

  • P/E Ratio (TTM)

    19.26

  • Beta

    0.17

  • Book Value / share

    44.97

  • Return on equity

    32.46%

  • EPS (TTM)

    5.08

  • Dividend yield

    %

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Asston Pharmaceuticals Ltd Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 25.04
Operating Expense 19.91
Net Profit 4.33
Net Profit Margin (%) 17.29
Earnings Per Share (EPS) 6.89
EBITDA 6.74
Effective Tax Rate (%) 24.03
Particulars MAR 2024 (Values in Cr)
Revenue 15.59
Operating Expense 14.02
Net Profit 1.36
Net Profit Margin (%) 8.72
Earnings Per Share (EPS) 17.35
EBITDA 2.80
Effective Tax Rate (%) 25.27
Particulars MAR 2023 (Values in Cr)
Revenue 6.54
Operating Expense 5.77
Net Profit 1.06
Net Profit Margin (%) 16.20
Earnings Per Share (EPS) 15.09
EBITDA 2.17
Effective Tax Rate (%) 25.53
Particulars MAR 2022 (Values in Cr)
Revenue 9.60
Operating Expense 10.39
Net Profit 0.11
Net Profit Margin (%) 1.14
Earnings Per Share (EPS) 1.58
EBITDA 0.60
Effective Tax Rate (%) 31.25
Particulars MAR 2024 (Values in Cr)
Book Value / Share 81.55
ROE % 32.46
ROCE % 26.61
Total Debt to Total Equity 1.44
EBITDA Margin 17.96
Particulars MAR 2023 (Values in Cr)
Book Value / Share 28.37
ROE % 72.60
ROCE % 36.93
Total Debt to Total Equity 2.93
EBITDA Margin 33.18
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.28
ROE % 11.83
ROCE % 13.75
Total Debt to Total Equity 3.56
EBITDA Margin 6.25
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 20.26
Total Liabilities 20.26
Total Equity 6.39
Share Outstanding 783920
Price to Book Ratio 0.00
Return on Assets (%) 6.71
Return on Capital (%) 10.3
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.12
Total Assets 13.69
Total Liabilities 13.69
Total Equity 1.98
Share Outstanding 700000
Price to Book Ratio 0.00
Return on Assets (%) 7.71
Return on Capital (%) 14.61
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.13
Total Assets 9.49
Total Liabilities 9.49
Total Equity 0.92
Share Outstanding 700000
Price to Book Ratio 0.00
Return on Assets (%) 1.16
Return on Capital (%) 2.61
Particulars MAR 2024 (Values in Cr)
Net Income 1.81
Cash from Operations -3.34
Cash from Investing 0.00
Cash from Financing 3.68
Net change in Cash -0.11
Free Cash Flow -3.33
Particulars MAR 2023 (Values in Cr)
Net Income 1.41
Cash from Operations -0.30
Cash from Investing -0.91
Cash from Financing 1.21
Net change in Cash -0.01
Free Cash Flow -0.05
Particulars MAR 2022 (Values in Cr)
Net Income 0.15
Cash from Operations -1.15
Cash from Investing 0.00
Cash from Financing 1.29
Net change in Cash 0.10
Free Cash Flow -1.15
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.16 12.72 1.70 238.79 30.00 / 69.50
BLISS GVS PHARMA LTD 158.10 15.64 1.58 1667.92 105.05 / 190.65
CIPLA LTD 1587.60 23.78 4.11 128239.04 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 322.55 9.08 2.61 949.30 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2804.55 50.17 24.34 47510.77 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 31.16 16.93 4.92 238.79 30.00 / 69.50
AMRUTAJAN HEALTH LTD 720.55 38.21 6.37 2083.16 548.05 / 838.00
ASTRAZENECA PHARMA IND LT 8751.75 103.46 28.40 21879.38 6222.35 / 10653.05
BLISS GVS PHARMA LTD 158.10 23.63 1.57 1667.92 105.05 / 190.65

Asston Pharmaceuticals Ltd Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
102.10 4.35 redarrow
red-green-graph indicator
3 Bearish
13 Bullish
  • 5 Days 100.40
  • 26 Days 108.80
  • 10 Days 102.50
  • 50 Days 111.10
  • 12 Days 103.20
  • 100 Days 111.10
  • 20 Days 106.30
  • 200 Days 111.10
99.62 PIVOT

First Support

95.23

First Resistance

102.22

Second Support

92.63

Second Resistance

106.61

Third Support

88.24

Third Resistance

109.21

RSI

31.97

ADX

11.72

MACD

-5.59

Williams % R

-90.62

Commodity Channel Index (CCI)

-102.64

Date

2025-09-01

Week

17400.00

Same Day

34000.00

Month

13750.00

1 Year

0.18

3 Year

0.31

Over 1 Month

-12.87%

down

Over 1 Year

0.00%

down

Over 3 Months

-21.69%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

Transparent Pricing, 360° Services

Choose a plan that best suits your goals & needs.

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Expert Stock Research tick Online Customer Support

Subscription Charge : 2500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Expert Stock Research tick Experienced Dealer Support

Asston Pharmaceuticals Ltd shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Name Shares Category

News

Left Arrow
Right Arrow

Asston Pharmaceuticals Ltd corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

Asston Pharmaceuticals Ltd Share Price

Asston Pharmaceuticals Limited was incorporated on 16th April 2019 as 'Asston Pharmaceutical Pvt. Limited' to contract produce pharmaceutical products for export market. Later on 1st April 2024, Company acquired Ferron Lifecare Private Limited, specializing into nutraceuticals business and produced nutraceutical products at their Ambarnath facility. Ferron Lifecare Private Limited, incorporated on 30th January 2020 was promoted by Dr. Ashish Sakalkar and Mr. Sachin Badakh. Finally, 'Asston Pharmaceuticals Private Limited' was converted from a Private Limited into a Public Limited Company in the name of 'Asston Pharmaceuticals Limited' on 29th August 2024 and received FDA approval for its Ambarnath facility on 2nd December 2024 to produce pharmaceutical products.

Company is engaged in the manufacturing and export of both pharmaceutical formulations and nutraceutical products in domestic and various African markets. It operates under brand 'Asston'. Presently, Company is involved in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel and Lotion) and Oral Powder (Sachet, Dry Syrup) etc.

Company's operations are supported by experienced founders with expertise in managing supply chains and maintaining product quality.
Currently, Company has its production plant at Ambernath, Maharashtra, for producing generic medicines in the tablet form and nutraceutical medicines in the tablet form, syrup and sachet form. Facility has total production capacity of up to around 8-9 crore tablets per month. Further, it produces an average of 5-6 crore tablets per month, with production capacity varying based on the weight of medicines. Higherweight medicines result in lower production quantities and vice versa. The syrup production capacity for nutraceuticals is approximately 37.5 kiloliters per month, while sachet production capacity ranges from 30 to 40 lakh sachets per month, depending on the powder weight per sachet. The facility is certified by relevant authorities and undergoes periodic audits by state and central FDA authorities. Company engages contract manufacturers to produce generic medicines and antibiotics in various forms, including tablets, sachets, syrups, and capsules.

Company is planning an Initial Public Issue of 22,41,600 Equity Shares of face value of Rs. 10/- through Fresh Issue.

Parent organization Indian Private
NSE symbol [-]
Founded 2019
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Asston Pharmaceuticals Ltd?

Answer Field

Asston Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 102.10 as on Sep 02 2025 03:26 PM.

What is the Market Cap of Asston Pharmaceuticals Ltd Share?

Answer Field

The market cap of Asston Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 86.90 as on Sep 02 2025 03:26 PM.

What is the 52 Week High and Low of Asston Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Asston Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 126.00 and ₹ 96.00.

What is 1 year return for Asston Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Asston Pharmaceuticals Ltd Share?

Answer Field

As on Sep 02 2025 03:26 PM the price-to-earnings (PE) ratio for Asston Pharmaceuticals Ltd share is 19.26.

What is the PB ratio of Asston Pharmaceuticals Ltd Share?

Answer Field

As on Sep 02 2025 03:26 PM, the price-to-book (PB) ratio for Asston Pharmaceuticals Ltd share is 44.97.

How to Buy Asston Pharmaceuticals Ltd Share?

Answer Field

You can trade in Asston Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Asston Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Asston Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Asston Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

close-image

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
close-image

Get Free Demat Account*

+91